Globus Medical Inc [GMED] stock prices are down -0.66% to $88.77 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The GMED shares have gain 3.47% over the last week, with a monthly amount glided 3.20%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Globus Medical Inc [NYSE: GMED] stock has seen the most recent analyst activity on November 07, 2025, when Truist upgraded its rating to a Buy but kept the price target unchanged to $93 for it. Previously, BofA Securities upgraded its rating to Buy on November 07, 2025, and kept the price target unchanged to $91. BTIG Research downgraded its rating to a Neutral. BofA Securities upgraded its rating to a Neutral but $97 remained the price target by the analyst firm on January 10, 2025. Morgan Stanley upgraded its rating to Overweight for this stock on December 02, 2024, and upped its price target to $100. In a note dated August 07, 2024, Wells Fargo upgraded an Overweight rating on this stock and boosted its target price from $60 to $78.
The stock price of Globus Medical Inc [GMED] has been fluctuating between $51.79 and $94.93 over the past year. Currently, Wall Street analysts expect the stock to reach $89.67 within the next 12 months. Globus Medical Inc [NYSE: GMED] shares were valued at $88.77 at the most recent close of the market. An investor can expect a potential return of 1.01% based on the average GMED price forecast.
Analyzing the GMED fundamentals
The Globus Medical Inc [NYSE:GMED] reported sales of 2.77B for trailing twelve months, representing a surge of 22.91%. Gross Profit Margin for this corporation currently stands at 0.47% with Operating Profit Margin at 0.13%, Pretax Profit Margin comes in at 0.17%, and Net Profit Margin reading is 0.15%. To continue investigating profitability, this company’s Return on Assets is posted at 0.08, Equity is 0.1 and Total Capital is 0.08. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 88.24 points at the first support level, and at 87.72 for the second support level. However, for the 1st resistance point, the stock is sitting at 89.57, and for the 2nd resistance point, it is at 90.38.
Ratios To Look Out For
It’s worth pointing out that Globus Medical Inc [NYSE:GMED]’s Current Ratio is 4.13. On the other hand, the Quick Ratio is 2.47, and the Cash Ratio is 0.8. Considering the valuation of this stock, the price to sales ratio is 4.31, the price to book ratio is 2.72 and price to earnings (TTM) ratio is 28.69.
Transactions by insiders
Recent insider trading involved Norwalk Leslie V, Director, that happened on Dec 12 ’25 when 4000.0 shares were sold. Director, Norwalk Leslie V completed a deal on Dec 12 ’25 to buy 4000.0 shares. Meanwhile, Senior Vice President, CFO Kline Kyle sold 18542.0 shares on Dec 01 ’25.
